论文部分内容阅读
目的分析阿莫西林联合果胶铋治疗慢性萎缩性胃炎的临床疗效。方法本研究所选128例慢性萎缩性胃炎均为我院2016年1月至2017年1月所收治,根据治疗方式的不同将全部患者分成两组,64例对照组患者选择阿莫西林治疗,64例实验组患者则选择阿莫西林联合果胶铋治疗,观察比较临床疗效。结果实验组患者的临床治疗总有效率89.1%(57/64)显著高于对照组患者的临床治疗总有效率81.40%(46/64),两者比较差异有统计学意义(P<0.05)。结论在对慢性萎缩性胃炎患者进行治疗时,选择阿莫西林联合果胶铋治疗能取得令人满意的效果,具有临床应用和推广价值。
Objective To analyze the clinical efficacy of amoxicillin combined with pectin bismuth in the treatment of chronic atrophic gastritis. Methods A total of 128 chronic atrophic gastritis selected in our study were admitted to our hospital from January 2016 to January 2017. All patients were divided into two groups according to the different treatment methods. Sixty-four patients in the control group were treated with amoxicillin, Sixty-four patients in the experimental group chose amoxicillin combined with bismuth pectin to observe and compare the clinical curative effect. Results The total effective rate of clinical treatment in experimental group was 89.1% (57/64), which was significantly higher than that in control group (81.40%, 46/64), the difference was statistically significant (P <0.05) . Conclusion In the treatment of patients with chronic atrophic gastritis, the choice of amoxicillin combined with pectin bismuth treatment can achieve satisfactory results, with clinical application and promotion of value.